Novel Triazole Functionalized Quinazolinone Derivatives, Their Anticancer Activity, and Docking Interactions
摘要
Abstract
A series of novel triazole functionalized quinazolinone derivatives were synthesized starting from 2-amino-6-(trifluoromethyl)benzonitrile. All the final compounds were evaluated for anticancer activity against four human cancer cell lines such as HeLa—cervical cancer (CCL-2), COLO 205—colon cancer (CCL-222), HepG2—liver cancer (HB-8065), MCF7—breast cancer (HTB-22), and promising compounds have been identified. Two compounds were further evaluated for molecular docking interactions.